Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1996
03/05/1996US5496837 Anti-neoplastic anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment
03/05/1996US5496836 Use of famotidine and related compounds in the treatment of movement disorders
03/05/1996US5496832 Method of treating cardiac inflammatory disease
03/05/1996US5496831 Rapamycins
03/05/1996US5496830 Inhibition of hemoflagellates by camptothecin compounds
03/05/1996US5496829 Use of 2-nitroxyethyl (+)apovincaminate
03/05/1996US5496828 Methods of inhibiting ulcerative mucositis
03/05/1996US5496827 Compositions for the transdermal delivery of nutrients
03/05/1996US5496826 Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
03/05/1996US5496823 Administering propentofylline or a salt thereof to a patient
03/05/1996US5496820 Ophthalmic use of S-timolol hemihydrate
03/05/1996US5496819 Drug delivery
03/05/1996US5496818 Oil-in-water type; dispersed lipid phase of vegetable oil, phospholipid emulsifier and strongly basic hydrophobic pharmaceutical; aqueous phase with buffer and small amount of ionized pharmaceutical; positive charge at emulsion interface
03/05/1996US5496816 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
03/05/1996US5496814 Steroids for bone disorders and oxidation resistance
03/05/1996US5496813 Spontaneously dispersible concentrates and aqueous microemulsions with steryl retinates having anti-tumor activity
03/05/1996US5496812 Topical preparation of tolnaftate and hydrocortisone to treat fungal infections of the skin
03/05/1996US5496809 Of water, 8-n-(diethylaminoethyl)rebeccamycin and a pharmaceutically acceptable acid
03/05/1996US5496808 Mono and bis alkylamino-anthracyclines
03/05/1996US5496807 Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it
03/05/1996US5496803 Administering prolactin by itself or with a glucosteroid such as cortisol
03/05/1996US5496731 Anti-oncogenes
03/05/1996US5496727 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
03/05/1996US5496569 Simultaneous treatment of osteoporosis and hypertension with potassium bicarbonate
03/05/1996US5496564 Suspendible composition and process for preparing the same
03/05/1996US5496558 Solid form xerostomia product
03/05/1996US5496556 Administering a steroid reductase inhibiting compound, an androstene derivative
03/05/1996US5496545 Phosphate-binding polymers for oral administration
03/05/1996US5496539 Oral compositions
03/05/1996US5496537 General anesthetics for nasal delivery using propofol with propellants
03/05/1996CA2085733C Polycyclic guanine derivatives
03/05/1996CA2056058C Corandomized fat compositions for infant formulas
03/05/1996CA2049940C Maillard's reaction inhibitor compositions
03/05/1996CA2043129C Antiviral glove
03/05/1996CA2010022C Anesthetic oral compositions
03/05/1996CA1338121C Anticonvulsant and neuroprotective 2-aminoacetamide derivatives
03/05/1996CA1338109C Pyridine derivatives and intermediates thereof
03/05/1996CA1338106C Finely divided solid crystalline powders via precipitation into an anti-solvent
03/03/1996CA2156753A1 Heterocyclic derivatives of n-phenylamides
03/03/1996CA2155705A1 Cephalosporin derivatives
03/03/1996CA2131438A1 Method and composition for treating intestinal wounds or ulcers
03/02/1996CA2157348A1 3-¬4-(1-substituted-4-piperazinyl)butyl|-4-thiazolidinone and related compounds
03/02/1996CA2157231A1 Oxa- or thia-aliphatically bridged quinoxaline-2,3-diones
03/01/1996CA2157240A1 Pharmaceutical formulation of nizatidine
03/01/1996CA2157236A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/01/1996CA2157235A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/01/1996CA2157156A1 New tetrahydropyranic compounds, process for their preparation and pharmaceutical composition containing them
03/01/1996CA2156961A1 Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments
03/01/1996CA2156960A1 Arylbenzoylguanidines
03/01/1996CA2156959A1 Ortho-substituted benzoic acid derivates
03/01/1996CA2131130A1 Modulation of cellular activity
02/1996
02/29/1996WO1996006176A1 Functional modified hsv1-tk
02/29/1996WO1996006103A2 α-D-PENTOFURANOSIDE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND THEIR USE
02/29/1996WO1996006101A1 Amino acid chelates having improved palatability
02/29/1996WO1996006098A1 Spiro-azabicyclic compounds useful in therapy
02/29/1996WO1996006097A1 New multimerizing agents
02/29/1996WO1996006095A1 Endothelin antagonists
02/29/1996WO1996006094A1 Novel substituted piperidines useful for the treatment of allergic diseases
02/29/1996WO1996006093A1 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
02/29/1996WO1996006091A1 Use of substituted 6-amino-4h-pyrans
02/29/1996WO1996006087A1 Bicyclic compounds
02/29/1996WO1996006084A1 Novel quinolylamine derivative, process for production thereof, and use thereof as antiarrhythmic agent
02/29/1996WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
02/29/1996WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists
02/29/1996WO1996006081A1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
02/29/1996WO1996006079A1 Biphenylamide derivatives as 5ht1d antagonists
02/29/1996WO1996006078A1 N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists
02/29/1996WO1996006077A1 N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists
02/29/1996WO1996006074A1 Metalloproteinase inhibitors
02/29/1996WO1996006069A1 D-b-lysylmethanediamine derivatives with bacteria, aids virus and tumor cell growth inhibiting activity and preparation thereof
02/29/1996WO1996005866A2 Live vaccine for the treatment of tumour diseases
02/29/1996WO1996005863A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use
02/29/1996WO1996005862A1 Use of porphine cationic derivative salts as gram-negative bacteria photosensitizers
02/29/1996WO1996005854A2 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative
02/29/1996WO1996005851A1 Use of tasteless, hydrolysed collagen and agent containing the same
02/29/1996WO1996005845A2 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction
02/29/1996WO1996005843A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol
02/29/1996WO1996005842A1 Intravenous alendronate formulations
02/29/1996WO1996005841A1 Pharmaceutical compositions comprising a dihydrofolate reductase inhibitor and a dihydropteroate synthetase inhibitor
02/29/1996WO1996005840A1 Methods and means for drug administration
02/29/1996WO1996005839A1 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
02/29/1996WO1996005838A2 Combined preparation for the therapy of immune diseases
02/29/1996WO1996005837A1 Use of n-substituted phenothiazines
02/29/1996WO1996005836A2 Methods of treating cold symptoms using pentoxifylline
02/29/1996WO1996005835A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure
02/29/1996WO1996005834A1 Improved pharmaceutical formulations containing ibuprofen and codeine
02/29/1996WO1996005833A1 Methods of inhibiting endometrial cancer
02/29/1996WO1996005832A1 Methods of inhibiting primary endometrial hyperplasia
02/29/1996WO1996005831A1 Methods of inhibiting ulcerative mucositis
02/29/1996WO1996005830A1 Methods of inhibiting viral replication
02/29/1996WO1996005829A1 Methods of maintaining teeth and oral bone
02/29/1996WO1996005828A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
02/29/1996WO1996005827A1 N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
02/29/1996WO1996005826A1 Methods of reducing scarring in wound healing
02/29/1996WO1996005825A1 Methods for bone healing and fracture repair
02/29/1996WO1996005824A1 Methods for inhibiting bone prosthesis degeneration
02/29/1996WO1996005823A1 Methods of inhibiting demyelinating and dysmyelinating diseases
02/29/1996WO1996005822A1 Surfactants and emulsifying agents to inhibit helicobacter
02/29/1996WO1996005821A1 Liposome-encapsulated taxol, its preparation and its use
02/29/1996WO1996005820A1 Hyperlipemia remedy
1 ... 6938 6939 6940 6941 6942 6943 6944 6945 6946 6947 6948 6949 6950 6951 6952 6953 6954 6955 6956 6957 6958 ... 7860